rs727503915
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001130987.2(DYSF):c.5642+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001130987.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuromuscular disease caused by qualitative or quantitative defects of dysferlinInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- autosomal recessive limb-girdle muscular dystrophy type 2BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- distal myopathy with anterior tibial onsetInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathy, Paradas typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Miyoshi myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| DYSF | NM_001130987.2 | c.5642+1G>A | splice_donor_variant, intron_variant | Intron 50 of 55 | ENST00000410020.8 | NP_001124459.1 | ||
| DYSF | NM_003494.4 | c.5525+1G>A | splice_donor_variant, intron_variant | Intron 49 of 54 | ENST00000258104.8 | NP_003485.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DYSF | ENST00000410020.8 | c.5642+1G>A | splice_donor_variant, intron_variant | Intron 50 of 55 | 1 | NM_001130987.2 | ENSP00000386881.3 | |||
| DYSF | ENST00000258104.8 | c.5525+1G>A | splice_donor_variant, intron_variant | Intron 49 of 54 | 1 | NM_003494.4 | ENSP00000258104.3 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy    Pathogenic:1 
Variant summary: DYSF c.5525+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 228924 control chromosomes. c.5525+1G>A has been reported in the literature in individuals affected with Limb-Girdle Muscular Dystrophy and Miyoshi myopathy (Cacciottolo_2011, Walter_2013), with one family reported as compound heterozygous, carrying a second (likely) pathogenic variant. These data indicate that the variant is likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, classifying the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1    Pathogenic:1 
- -
not provided    Pathogenic:1 
- -
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin    Pathogenic:1 
Studies have shown that disruption of this splice site results in skipping of exon 49, but is expected to preserve the integrity of the reading-frame (PMID: 21522182). This variant disrupts a region of the DYSF protein in which other variant(s) (p.Asp1837Asn) have been determined to be pathogenic (PMID: 11257469, 22194990). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 167030). This sequence change affects a donor splice site in intron 49 of the DYSF gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with DYSF-related conditions (PMID: 21522182). -
Miyoshi muscular dystrophy 1    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at